Biography
Dr Wicks is the product of Whitney M. Young High School in Chicago, Illinois, where she was a Science major, Dance (Jazz, Modern, Tap) and Music (Mixed Chorus)major. She received her Bachelors in Biological Sciences, with a minor in Chemistry at University of Illinois in Chicago, Graduate and Doctoral work at University of Illinois in Natural Products, Medicinal Chemistry and Pharmacognosy, While working in the Health Food Industry as an Education Specialist for Sherwyns Health Foods, Whole Food Markets, Fresh Fields, and other Nutrition Markets, Sheila received a Masters in Science in Biological Sciences at Chicago State University. This Masters degree emphasized Molecular Biology and Microbial Genetics. She later pursued a Masters in Acupuncture from Midwest College of Oriental Medicine, in Wisconsin, and later obtained a Medical Diploma from Guangzhou Medical University, in the Peoples Republic of China. While working as a Biotechnology Consultant for Clients such as Abbott, Pfizer, Neopharm and other Biopharmaceutical Corporations, she completed a MBA with a concentration in Health Services and Policy from Keller Graduate School of Management. In between this time she was selected as an NBC Health & Medical Intern, producing, reporting and writing health stories. , She then became an Active Participant in Oprah Winfrey’s Course on Leadership, at Kellogg Graduate School of Management. Dr Wicks worked and trained under the auspices of Dr Joel Shepherd, MD from 1992 until 2001. and trained in Natural Products & Nutrition Assessment in Oncology, Neurology, Internal Medicine, Family Medicine, Gastroenterology, Pediatrics, Psychiatry, Surgery and others.She was appointed as a Volunteer Attending and Faculty at John Stroger Hospital in the Department of Anesthesia & Pain Management and worked diligently at, using Natural Products with Medical Acupuncture and Medical Nutrition Assessment. At the University of Illinois at Chicago in the Department of Pharmacognosy from 1998 to 2011, she was under the mentorship of the late Dr Norman Farnsworth, world expert in Natural Products. and worked with the coding, pharmacology, and review of Natural compounds from such countries as America, Africa, Asia, India, Europe and Iran. Additionally, she also trained at University of Chicago in Clinical & Medical research, where she is still an active Research member in Natural Products
Abstract
This study investigated the in vivo anti-inflammatory effects of Boswellia serrata and Ocimum sanctum in HL-60 cells and in OVA- induced inflammatory lung disease in BALB/Cmice. The plant materials were collected from India The Extract and fractions were tested for their effects on leukotriene C4 synthase leukotriene A4 hydrolase and cyclooxygenase 2 in HL-60 cells . The results showed significant inhibition in in vivo and in vitro inflammation suggesting a plausible mechanism of action for the management of asthma.
Biography
Samreen Ahmed has completed her MBBS at the age of 24 years from Dow Medical College, Pakistan, and currently volunteering as a Research Assistant at University of Illinois at chicago. Dr. Ahmed has written 3 case reports as a first author that were published in the IJBCP.
Abstract
Elderly patients, over 65 years of age, most commonly suffer from dementia due to Alzheimer’s Disease. In 1907, Alois Alzheimer first described this disease. Alzheimer’s disease, is clinically diagnosed, after ruling out other possible causes of dementia which makes it a diagnosis of exclusion. Its etiology is based on certain genetic, neurobiochemical, and other factors. Radiographically, diffuse atrophy of the brain is seen in patients with AD. Donepezil, a cholinesterase inhibitor, increases the level of acetylcholine by reducing its inactivation hence leads to improvement in memory. To evaluate the effectiveness of Donepezil in declining the progression of Alzheimer’s Disease. A review of literature related to the effects of Donepezil in reducing Alzheimer’s Disease progression was conducted on MEDLINE, PSYCH Info, and PUBMED. Commonly used cholinesterase inhibitors, donepezil, galantamine, and rivastigmine help with the symptoms of Alzheimer’s disease, however, in terms of efficacy, there is no clear evidence of difference among them. According to a research in 2015, its suggested to monitor the serum levels of donepezil for improving its effectiveness, and a serum level of at least 50ng/mL is may be the recommended level for donepezil to produce its maximal clinical effect. A systematic review in 2015, revealed that ChEIs are effective for cognition, although their effects for neuropsychiatric symptoms in patients with mild to moderate AD is controversial. In spite of the fact that the side effects of ACEIs are mild, although they can be serious in advanced cases of AD hence require proper monitoring for the serious side effects, particularly, syncope and bradycardia. Cases relevant to the side effects of donepezil reported increased libido, myoclonus, and cervical dystonia. Interestingly, improved gait in patients of AD with mild nature, was reported by a clinical trial. Beneficial effects of donepezil in memory improvement, seen in patients with Alzheimer’s disease, is revealed by literature review of previous researches. We recommend administering donepezil to patients with Alzheimer’s disease thereby improving their memory, and quality of life. We hope that future research in this area will help patients with dementia and improving their ADLs.